causal
For people with type 2 diabetes and heart disease, a weekly injection of semaglutide lowers their chance of having a heart attack, stroke, or dying from heart problems by about a quarter.
Evidence from Studies
No evidence studies found yet.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.